INS and obesity disorder: The administration of HFD to control mice increased body weight, obesity, serum insulin, and decreased glucose tolerance, whereas HDAC3ΔIEC mice fed by HFD did not develop obesity and showed reduced serum triglyceride levels, less hepatic fat, and smaller adipocytes compared to HFD-fed control mice.